MEDGENICS INC - COM NEW (MDGN)

CUSIP: 58436Q203

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM NEW
Total 13F shares
5,304,562
Share change
+3,418,103
Total reported value
$26,842,745
Price per share
$5.06
Number of holders
38
Value change
+$17,263,108
Number of buys
23
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 58436Q203?
CUSIP 58436Q203 identifies MDGN - MEDGENICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDGENICS INC - COM NEW (MDGN) as of Q4 2014

As of 31 Dec 2014, MEDGENICS INC - COM NEW (MDGN) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,304,562 shares. The largest 10 holders included Broadfin Capital, LLC, JENNISON ASSOCIATES LLC, Opaleye Management Inc., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BlackRock Institutional Trust Company, N.A., SPHERA FUNDS MANAGEMENT LTD., GEODE CAPITAL MANAGEMENT, LLC, and Alyeska Investment Group, L.P.. This page lists 38 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.